ADAPTHEALTH CORP (AHCO) Fundamental Analysis & Valuation

NASDAQ:AHCO • US00653Q1022

9.4 USD
-0.24 (-2.49%)
At close: Mar 3, 2026
9.4 USD
0 (0%)
After Hours: 3/3/2026, 8:00:01 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This AHCO fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

3

Overall AHCO gets a fundamental rating of 3 out of 10. We evaluated AHCO against 101 industry peers in the Health Care Providers & Services industry. There are concerns on the financial health of AHCO while its profitability can be described as average. AHCO has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

4

1. AHCO Profitability Analysis

1.1 Basic Checks

  • In the past year AHCO has reported negative net income.
  • AHCO had a positive operating cash flow in the past year.
  • In multiple years AHCO reported negative net income over the last 5 years.
  • AHCO had a positive operating cash flow in each of the past 5 years.
AHCO Yearly Net Income VS EBIT VS OCF VS FCFAHCO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M 400M -400M 600M -600M

1.2 Ratios

  • The Return On Assets of AHCO (-1.63%) is comparable to the rest of the industry.
  • Looking at the Return On Equity, with a value of -4.63%, AHCO is in line with its industry, outperforming 47.52% of the companies in the same industry.
  • Looking at the Return On Invested Capital, with a value of 3.98%, AHCO is in line with its industry, outperforming 48.51% of the companies in the same industry.
  • AHCO had an Average Return On Invested Capital over the past 3 years of 4.65%. This is below the industry average of 9.13%.
Industry RankSector Rank
ROA -1.63%
ROE -4.63%
ROIC 3.98%
ROA(3y)-4.95%
ROA(5y)-2.19%
ROE(3y)-15.31%
ROE(5y)-7.22%
ROIC(3y)4.65%
ROIC(5y)3.98%
AHCO Yearly ROA, ROE, ROICAHCO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 -40

1.3 Margins

  • The Operating Margin of AHCO (6.34%) is better than 70.30% of its industry peers.
  • AHCO's Operating Margin has improved in the last couple of years.
  • AHCO has a Gross Margin of 21.07%. This is comparable to the rest of the industry: AHCO outperforms 46.53% of its industry peers.
  • In the last couple of years the Gross Margin of AHCO has grown nicely.
Industry RankSector Rank
OM 6.34%
PM (TTM) N/A
GM 21.07%
OM growth 3Y-0.39%
OM growth 5Y3.26%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y8.81%
GM growth 5Y5%
AHCO Yearly Profit, Operating, Gross MarginsAHCO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 20 -20

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

1

2. AHCO Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), AHCO is destroying value.
  • The number of shares outstanding for AHCO has been increased compared to 1 year ago.
  • AHCO has more shares outstanding than it did 5 years ago.
  • AHCO has a better debt/assets ratio than last year.
AHCO Yearly Shares OutstandingAHCO Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
AHCO Yearly Total Debt VS Total AssetsAHCO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B 5B

2.2 Solvency

  • AHCO has an Altman-Z score of 0.98. This is a bad value and indicates that AHCO is not financially healthy and even has some risk of bankruptcy.
  • The Altman-Z score of AHCO (0.98) is worse than 66.34% of its industry peers.
  • AHCO has a debt to FCF ratio of 8.14. This is a slightly negative value and a sign of low solvency as AHCO would need 8.14 years to pay back of all of its debts.
  • The Debt to FCF ratio of AHCO (8.14) is comparable to the rest of the industry.
  • AHCO has a Debt/Equity ratio of 1.15. This is a high value indicating a heavy dependency on external financing.
  • With a Debt to Equity ratio value of 1.15, AHCO is not doing good in the industry: 62.38% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 1.15
Debt/FCF 8.14
Altman-Z 0.98
ROIC/WACC0.56
WACC7.14%
AHCO Yearly LT Debt VS Equity VS FCFAHCO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M 1B 1.5B 2B

2.3 Liquidity

  • AHCO has a Current Ratio of 1.02. This is a normal value and indicates that AHCO is financially healthy and should not expect problems in meeting its short term obligations.
  • AHCO has a Current ratio of 1.02. This is in the lower half of the industry: AHCO underperforms 68.32% of its industry peers.
  • AHCO has a Quick Ratio of 1.02. This is a bad value and indicates that AHCO is not financially healthy enough and could expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 0.81, AHCO is doing worse than 75.25% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.02
Quick Ratio 0.81
AHCO Yearly Current Assets VS Current LiabilitesAHCO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. AHCO Growth Analysis

3.1 Past

  • The earnings per share for AHCO have decreased strongly by -230.00% in the last year.
  • Looking at the last year, AHCO shows a very negative growth in Revenue. The Revenue has decreased by -19.95% in the last year.
  • AHCO shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 25.16% yearly.
EPS 1Y (TTM)-230%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-323.53%
Revenue 1Y (TTM)-19.95%
Revenue growth 3Y2.99%
Revenue growth 5Y25.16%
Sales Q2Q%-1.21%

3.2 Future

  • The Earnings Per Share is expected to grow by 33.39% on average over the next years. This is a very strong growth
  • The Revenue is expected to grow by 6.53% on average over the next years.
EPS Next Y229.95%
EPS Next 2Y90.01%
EPS Next 3Y53.13%
EPS Next 5Y33.39%
Revenue Next Year7.34%
Revenue Next 2Y7.14%
Revenue Next 3Y6.53%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
AHCO Yearly Revenue VS EstimatesAHCO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1B 2B 3B
AHCO Yearly EPS VS EstimatesAHCO Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 1 -1 -2

More info and screens

Find the best growth stocksShow best growing peers

6

4. AHCO Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for AHCO. In the last year negative earnings were reported.
  • AHCO is valuated reasonably with a Price/Forward Earnings ratio of 9.27.
  • AHCO's Price/Forward Earnings ratio is rather cheap when compared to the industry. AHCO is cheaper than 91.09% of the companies in the same industry.
  • AHCO is valuated cheaply when we compare the Price/Forward Earnings ratio to 24.95, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 9.27
AHCO Price Earnings VS Forward Price EarningsAHCO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 30

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, AHCO is valued cheaper than 92.08% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, AHCO is valued cheaper than 94.06% of the companies in the same industry.
Industry RankSector Rank
P/FCF 5.82
EV/EBITDA 5.03
AHCO Per share dataAHCO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • AHCO's earnings are expected to grow with 53.13% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y90.01%
EPS Next 3Y53.13%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. AHCO Dividend Analysis

5.1 Amount

  • No dividends for AHCO!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

AHCO Fundamentals: All Metrics, Ratios and Statistics

ADAPTHEALTH CORP

NASDAQ:AHCO (3/3/2026, 8:00:01 PM)

After market: 9.4 0 (0%)

9.4

-0.24 (-2.49%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)02-24
Earnings (Next)05-04
Inst Owners93.73%
Inst Owner Change0.93%
Ins Owners1.81%
Ins Owner Change5.74%
Market Cap1.28B
Revenue(TTM)3.24B
Net Income(TTM)-70.27M
Analysts81.43
Price Target13.64 (45.11%)
Short Float %6.41%
Short Ratio6.8
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-174.1%
Min EPS beat(2)-312.88%
Max EPS beat(2)-35.31%
EPS beat(4)0
Avg EPS beat(4)-471.13%
Min EPS beat(4)-1325.49%
Max EPS beat(4)-35.31%
EPS beat(8)1
Avg EPS beat(8)-252.52%
EPS beat(12)3
Avg EPS beat(12)-252.41%
EPS beat(16)3
Avg EPS beat(16)-207.71%
Revenue beat(2)1
Avg Revenue beat(2)0.19%
Min Revenue beat(2)-0.23%
Max Revenue beat(2)0.61%
Revenue beat(4)1
Avg Revenue beat(4)-0.57%
Min Revenue beat(4)-2.38%
Max Revenue beat(4)0.61%
Revenue beat(8)3
Avg Revenue beat(8)-0.5%
Revenue beat(12)5
Avg Revenue beat(12)-0.41%
Revenue beat(16)7
Avg Revenue beat(16)-0.16%
PT rev (1m)0.94%
PT rev (3m)0.94%
EPS NQ rev (1m)-2.78%
EPS NQ rev (3m)-11.11%
EPS NY rev (1m)0%
EPS NY rev (3m)-9.58%
Revenue NQ rev (1m)-0.11%
Revenue NQ rev (3m)-0.11%
Revenue NY rev (1m)-0.03%
Revenue NY rev (3m)-0.17%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 9.27
P/S 0.39
P/FCF 5.82
P/OCF 2.12
P/B 0.84
P/tB N/A
EV/EBITDA 5.03
EPS(TTM)-0.78
EYN/A
EPS(NY)1.01
Fwd EY10.78%
FCF(TTM)1.61
FCFY17.17%
OCF(TTM)4.43
OCFY47.1%
SpS23.88
BVpS11.17
TBVpS-8.15
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -1.63%
ROE -4.63%
ROCE 5.71%
ROIC 3.98%
ROICexc 4.1%
ROICexgc 16.44%
OM 6.34%
PM (TTM) N/A
GM 21.07%
FCFM 6.76%
ROA(3y)-4.95%
ROA(5y)-2.19%
ROE(3y)-15.31%
ROE(5y)-7.22%
ROIC(3y)4.65%
ROIC(5y)3.98%
ROICexc(3y)4.77%
ROICexc(5y)4.1%
ROICexgc(3y)18.14%
ROICexgc(5y)17.62%
ROCE(3y)6.67%
ROCE(5y)5.71%
ROICexgc growth 3Y7.72%
ROICexgc growth 5Y-6.09%
ROICexc growth 3Y13.34%
ROICexc growth 5Y5.89%
OM growth 3Y-0.39%
OM growth 5Y3.26%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y8.81%
GM growth 5Y5%
F-Score3
Asset Turnover0.75
Health
Industry RankSector Rank
Debt/Equity 1.15
Debt/FCF 8.14
Debt/EBITDA 2.98
Cap/Depr 100.12%
Cap/Sales 11.78%
Interest Coverage 2.03
Cash Conversion 102.41%
Profit Quality N/A
Current Ratio 1.02
Quick Ratio 0.81
Altman-Z 0.98
F-Score3
WACC7.14%
ROIC/WACC0.56
Cap/Depr(3y)90.69%
Cap/Depr(5y)92.45%
Cap/Sales(3y)10.57%
Cap/Sales(5y)10.63%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-230%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-323.53%
EPS Next Y229.95%
EPS Next 2Y90.01%
EPS Next 3Y53.13%
EPS Next 5Y33.39%
Revenue 1Y (TTM)-19.95%
Revenue growth 3Y2.99%
Revenue growth 5Y25.16%
Sales Q2Q%-1.21%
Revenue Next Year7.34%
Revenue Next 2Y7.14%
Revenue Next 3Y6.53%
Revenue Next 5YN/A
EBIT growth 1Y-43.79%
EBIT growth 3Y2.59%
EBIT growth 5Y29.25%
EBIT Next Year175.81%
EBIT Next 3Y46.97%
EBIT Next 5YN/A
FCF growth 1Y-6.96%
FCF growth 3YN/A
FCF growth 5Y7.08%
OCF growth 1Y11.06%
OCF growth 3Y17.19%
OCF growth 5Y25.2%

ADAPTHEALTH CORP / AHCO FAQ

What is the ChartMill fundamental rating of ADAPTHEALTH CORP (AHCO) stock?

ChartMill assigns a fundamental rating of 3 / 10 to AHCO.


What is the valuation status of ADAPTHEALTH CORP (AHCO) stock?

ChartMill assigns a valuation rating of 6 / 10 to ADAPTHEALTH CORP (AHCO). This can be considered as Fairly Valued.


How profitable is ADAPTHEALTH CORP (AHCO) stock?

ADAPTHEALTH CORP (AHCO) has a profitability rating of 4 / 10.